Overview and Scope
The lupus therapeutics market consists of revenues earned by entities by providing services such as autoantibody testing, anti-phospholipid antibody testing, and rheumatoid factor testing. The market value includes the value of related goods sold by the service provider or included within the service offering. The lupus therapeutics market also includes sales of calcineurin inhibitors, immunosuppressants, anticoagulants, and antimalarial drugs. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
Sizing and Forecast
The lupus therapeutics market size has grown strongly in recent years. It will grow from $2.53 billion in 2023 to $2.74 billion in 2024 at a compound annual growth rate (CAGR) of 8.6%. The growth in the historic period can be attributed to the increased prevalence of lupus, increased investment in healthcare infrastructure, high disposable income, high demand for effective therapies, and rising geriatric population.
The lupus therapeutics market size is expected to see strong growth in the next few years. It will grow to $3.83 billion in 2028 at a compound annual growth rate (CAGR) of 8.7%. The growth in the forecast period can be attributed to rising drug approvals and launches, emerging markets, improvements in disease awareness and diagnosis, rising awareness initiatives, and immunosuppressive products. Major trends in the forecast period include chimeric antigen receptor T-cell (CAR-T) therapy, small molecule therapeutics for lupus, CAR-NK therapy for lupus, combined inhibition of human plasmacytoid dendritic cell activity during systemic lupus, erythematosus (SLE), urine proteomics.
Order your report now for swift delivery, visit the link:
https://www.thebusinessresearchcompany.com/report/lupus-therapeutics-global-market-report
Segmentation & Regional Insights
The lupus therapeutics market covered in this report is segmented –
1) By Disease Type: Systemic Lupus Erythematosus (SLE), Cutaneous Lupus Erythematosus, Drug-Induced Lupus Erythematosus, Neonatal Lupus
2) By Treatment Type: Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), Biologics, Antimalarial Drugs, Corticosteroids, Other Treatment Types
3) By Route Of Administration: Oral, Subcutaneous, Intravenous, Other Routes Of Administration
4) By End User: Hospitals And Clinics, Diagnostic Laboratories, Other End Users
North America was the largest region in the lupus therapeutics market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the lupus therapeutics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Intrigued to explore the contents? Secure your hands-on a free sample copy of the report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=16471&type=smp
Major Driver Impacting Market Growth
The increasing research and development activities are expected to propel the growth of the lupus therapeutics market going forward. Research and development activities refer to systematic investigation and experimentation aimed at advancing knowledge, technology, or product development in various fields. The increasing research and development activities is often driven by the need for innovation, advancements in technology, addressing emerging challenges, improving healthcare outcomes, and fostering economic growth through scientific discoveries and technological breakthroughs. Research and development activities help advance lupus therapeutics by discovering new treatments, improving existing therapies, and understanding the underlying mechanisms of the disease. For instance, in March 2023, according to a report published by the Congressional Research Service, a US-based federal legislative branch agency, the national institutes of health received $49.183 billion in 2023 for research and development activities, marking an increase from $42.941 billion allocated in 2021. Therefore, the increasing research and development activities are driving the growth of the lupus therapeutics market.
Key Industry Players
Major companies operating in the lupus therapeutics market are Pfizer Inc., Johnson & Johnson, Merck & Co. Inc., AbbVie Inc., Sanofi SA, AstraZeneca PLC, Novartis AG, Roche Holdings Inc., GlaxoSmithKline plc, Eli Lilly and Company, Viatris Inc., Teva Pharmaceutical Industries Ltd., Bausch Health Companies Inc., Sun Pharmaceutical Industries Ltd., Aurobindo Pharma, Dr. Reddy’s Laboratories Ltd., Hikma Pharmaceuticals PLC, Amneal Pharmaceuticals LLC, Lupin Ltd, Zydus Lifesciences Limited, Glenmark Pharmaceuticals Limited
The lupus therapeutics market report table of contents includes:
1. Executive Summary
2. Lupus Therapeutics Market Characteristics
3. Lupus Therapeutics Market Trends And Strategies
4. Lupus Therapeutics Market – Macro Economic Scenario
5. Global Lupus Therapeutics Market Size and Growth
.
.
.
27. Competitive Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix
Explore the trending research reports from TBRC:
https://www.thebusinessresearchcompany.com/report/peptide-therapeutics-global-market-report
https://www.thebusinessresearchcompany.com/report/liver-diseases-therapeutics-global-market-report
https://www.thebusinessresearchcompany.com/report/hypertrophic-cardiomyopathy-hcm-therapeutics-global-market-report
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
